Therapeutic Applications of Iminosugars: Current Perspectives and Future Opportunities

TGF-β SIGNAL TRANSDUCTION

Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,571

Biological roles of oligosaccharides: all of the theories are correct

Varki, A. P. (1993) · Glycobiology · doi:10.1093/glycob/3.2.97 · Cited by 5,229

Glycosylation in Cellular Mechanisms of Health and Disease

Ohtsubo, K., & Marth, J. D. (2006) · Cell · doi:10.1016/j.cell.2006.08.019 · Cited by 2,818

Glycobiology: Toward Understanding the Function of Sugars

Dwek, R. A. (1996) · Chemical Reviews · doi:10.1021/cr940283b · Cited by 2,800

Essentials of Glycobiology

Varki, A. P., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., & Etzler, M. E. (1999) · Cited by 2,384

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work.

Buée, L., Bussière, T., Buée‐Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,142

Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease

Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901281 · Cited by 2,135

Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds

Spiro, R. G. (2002) · Glycobiology · doi:10.1093/glycob/12.4.43r · Cited by 1,414

GLYCOBIOLOGY

Rademacher, T. W., Parekh, R. B., & Dwek, R. A. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.004033 · Cited by 1,144

Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.

Hakomori, S. (1996) · PubMed · Cited by 987

O-glycosylation of eukaryotic transcription factors: Implications for mechanisms of transcriptional regulation

Jackson, S. P., & Tjian, R. (1988) · Cell · doi:10.1016/0092-8674(88)90015-3 · Cited by 901

Fabry's disease

Zárate, Y. A., & Hopkin, R. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61589-5 · Cited by 797

Pompe's disease

van der Ploeg, A. T., & Reuser, A. J. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61555-x · Cited by 781

O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease

Liu, F., Iqbal, K., Grundke-Iqbal, I., Hart, G. W., & Gong, C.-X. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400348101 · Cited by 775

Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins

Gao, Y., Wells, L., Comer, F. I., Parker, G. J., & Hart, G. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010420200 · Cited by 757

Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease

Frölich, L., Blum-Degen, D., Bernstein, H.-G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A., Türk, A., Hoyer, S., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050068 · Cited by 748

Dynamic Glycosylation of Nuclear and Cytosolic Proteins

Kreppel, L. K., Blomberg, M. A., & Hart, G. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.9308 · Cited by 747

A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo

Yuzwa, S. A., Macauley, M. S., Heinonen, J. E., Shan, X., Dennis, R. J., He, Y., Whitworth, G. E., Stubbs, K. A., McEachern, E. J., Davies, G. J., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.96 · Cited by 717

Glycosidase inhibitors: update and perspectives on practical use

Asano, N. (2003) · Glycobiology · doi:10.1093/glycob/cwg090 · Cited by 717

Glucocerebrosidase mutations in clinical and pathologically proven Parkinson’s disease

Neumann, J., Bras, J., Deas, E., O'Sullivan, S. S., Parkkinen, L., Lachmann, R. H., Li, A., Holton, J., Guerreiro, R., Paudel, R., et al. (2009) · Brain · doi:10.1093/brain/awp044 · Cited by 696

Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase

Gruters, R. A., Neefjes, J., Tersmette, M., de Goede, R. E. Y., Tulp, A., Huisman, H. G., Miedema, F. F., & Ploegh, H. L. (1987) · Nature · doi:10.1038/330074a0 · Cited by 578

Curcumin, a Major Constituent of Turmeric, Corrects Cystic Fibrosis Defects

Egan, M. E., Pearson, M., Weiner, S. A., Rajendran, V., Rubin, D., Glöckner-Pagel, J., Canny, S., Du, K., Lukács, G. L., & Caplan, M. J. (2004) · Science · doi:10.1126/science.1093941 · Cited by 562

Mucin‐type O‐glycans in human colon and breast cancer: glycodynamics and functions

Brockhausen, I. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400705 · Cited by 512

Shiga toxins — from cell biology to biomedical applications

Johannes, L., & Römer, W. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2279 · Cited by 511

Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol.

Dong, D. L., & Hart, G. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32170-1 · Cited by 508

Amino-sugar glycosidase inhibitors: versatile tools for glycobiologists

WINCHESTER, B. G., & Fleet, G. W. J. (1992) · Glycobiology · doi:10.1093/glycob/2.3.199 · Cited by 497

Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes

Vosseller, K., Wells, L., Lane, M. D., & Hart, G. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072072399 · Cited by 494

Genetic defects in the human glycome

Freeze, H. H. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1894 · Cited by 469

Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases

Mazanetz, M. P., & Fischer, P. M. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2111 · Cited by 459

O-GlcNAc Modification Is an Endogenous Inhibitor of the Proteasome

Zhang, F., Su, K., Yang, X., Bowe, D. B., Paterson, A. J., & Kudlow, J. E. (2003) · Cell · doi:10.1016/s0092-8674(03)00974-7 · Cited by 432

O-linked β-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress

Butkinaree, C., Park, K., & Hart, G. W. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.07.018 · Cited by 430

A Spectroscopic Investigation of Swainsonine: An α-Mannosidase Inhibitor Isolated from Swainsona canescens

Colegate, S., Dorling, P., & Huxtable, C. (1979) · Australian Journal of Chemistry · doi:10.1071/ch9792257 · Cited by 429

Generalized Gangliosidosis: Beta-Galactosidase Deficiency

Okada, S., & O’Brien, J. S. (1968) · Science · doi:10.1126/science.160.3831.1002 · Cited by 428

Clostridium difficile Infection

Kelly, C. P., & LaMont, J. T. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.375 · Cited by 413

RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc

Kelly, W. G., Dahmus, M. E., & Hart, G. W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82216-5 · Cited by 407

Ovarian Cancer is Associated with Changes in Glycosylation in Both Acute-Phase Proteins and IgG

Saldova, R., Royle, L., Radcliffe, C. M., Hamid, U. M. A., Evans, R., Arnold, J. N., Banks, R. E., Hutson, R., Harvey, D. J., Antrobus, R., et al. (2007) · Glycobiology · doi:10.1093/glycob/cwm100 · Cited by 397

Polyhydroxylated Alkaloids Isolated from Mulberry Trees (Morus alba L.) and Silkworms (Bombyx mori L.)

Asano, N., Yamashita, T., Yasuda, K., Ikeda, K., Kizu, H., Kameda, Y., Kato, A., Nash, R. J., Lee, H.-S., & Ryu, K. (2001) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf010567e · Cited by 391

The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives

Pavlović, D., Neville, D. C. A., Argaud, O., Blumberg, B., Dwek, R. A., Fischer, W. B., & Zitzmann, N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031527100 · Cited by 390

Cell signaling, the essential role of O-GlcNAc

Zachara, N. E., & Hart, G. W. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.04.007 · Cited by 386

Castanospermine, A 1,6,7,8-tetrahydroxyoctahydroindolizine alkaloid, from seeds of Castanospermum australe

Hohenschutz, L. D., Bell, E. A., Jewess, P. J., Leworthy, D. P., Pryce, R. J., Arnold, E., & Clardy, J. (1981) · Phytochemistry · doi:10.1016/0031-9422(81)85181-3 · Cited by 383

Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins. Identification of a uridine diphospho-N-acetylglucosamine:peptide beta-N-acetylglucosaminyltransferase.

Haltiwanger, R. S., Holt, G. D., & Hart, G. W. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39838-2 · Cited by 372

Hepatitis C Virus p7 Protein Is Crucial for Assembly and Release of Infectious Virions

Steinmann, E., Pénin, F., Kallis, S., Patel, A. H., Bartenschlager, R. F. W., & Pietschmann, T. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030103 · Cited by 372

Neurodegenerative lysosomal disorders: A continuum from development to late age

Nixon, R. A., Yang, D.-S., & Lee, J.-H. (2008) · Autophagy · doi:10.4161/auto.6259 · Cited by 362

Ganglioside GM3 Participates in the Pathological Conditions of Insulin Resistance

Tagami, S., Inokuchi, J.-I., Kabayama, K., Yoshimura, H., Kitamura, F., Uemura, S., Ogawa, C., Ishii, A., Saito, M., Ohtsuka, Y., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m103705200 · Cited by 355

Inhibition of HIV replication by amino‐sugar derivatives

Fleet, G. W. J., Karpas, A., Dwek, R. A., Fellows, L. E., Tyms, A. S., Petursson, S., Namgoong, S. K., Ramsden, N. G., Smith, P. W., Son, J. C., et al. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80185-6 · Cited by 349

Aminosugar derivatives as potential anti-human immunodeficiency virus agents.

Karpas, A., Fleet, G. W. J., Dwek, R. A., Petursson, S., Namgoong, S. K., Ramsden, N. G., Jacob, G. S., & Rademacher, T. W. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9229 · Cited by 339

Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine.

Walker, B. D., Kowalski, M. M., Goh, W. C., Kozarsky, K., Krieger, M., Rosen, C. A., Rohrschneider, L. R., Haseltine, W. A., & Sodroski, J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.22.8120 · Cited by 337

Iminosugars-From Synthesis to Therapeutic Applications

Ranade, V. (2008) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e318172886d · Cited by 328

Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: Implications for the development of broad spectrum anti-hepatitis virus agents

Zitzmann, N., Mehta, A. S., Carrouée‐Durantel, S., Butters, T. D., Platt, F. M., McCauley, J. A., Blumberg, B. S., Dwek, R. A., & Block, T. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11878 · Cited by 326

Iminosugars past, present and future: Medicines for tomorrow

Horne, G., Wilson, F. X., Tinsley, J., Williams, D. H., & Storer, R. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2010.08.017 · Cited by 320

Hypersialylation of β1 Integrins, Observed in Colon Adenocarcinoma, May Contribute to Cancer Progression by Up-regulating Cell Motility

Seales, E. C., Jurado, G. A., Brunson, B. A., Wakefield, J., Frost, A. R., & Bellis, S. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3117 · Cited by 316

Microbial Glycobiology

Moran, A. P., Holst, O., Brennan, P. J., & von Itzstein, M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374546-0.x0001-6 · Cited by 310

Pharmacological Inhibition of Glucosylceramide Synthase Enhances Insulin Sensitivity

Aerts, J. M. F. G., Ottenhoff, R., Powlson, A., Grefhorst, A., van Eijk, M., Dubbelhuis, P. F., Aten, J., Kuipers, F., Serlie, M. J. M., Wennekes, T., et al. (2007) · Diabetes · doi:10.2337/db06-1619 · Cited by 301

Castanospermine, a Potent Inhibitor of Dengue Virus Infection In Vitro and In Vivo

Whitby, K., Pierson, T. C., Geiss, B. J., Lane, K. C., Engle, M. J., Zhou, Y., Doms, R. W., & Diamond, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.8698-8706.2005 · Cited by 297

Cystic fibrosis: a disease of vulnerability to airway surface dehydration

Boucher, R. C. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.05.001 · Cited by 280

Glycosylation inhibitors in biology and medicine

Jacob, G. S. (1995) · Current Opinion in Structural Biology · doi:10.1016/0959-440x(95)80051-4 · Cited by 279

Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics

Parenti, G. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900036 · Cited by 277

Consequences of NPC1 and NPC2 loss of function in mammalian neurons

Walkley, S. U., & Suzuki, K. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.08.011 · Cited by 274

Modulation of transcription factor function by O-GlcNAc modification

Özcan, S., Andrali, S. S., & Cantrell, J. E. L. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.02.005 · Cited by 256

Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease

Clark, L. N., Ross, B., Wang, Y., Mejia‐Santana, H., Harris, J. M., Louis, E. D., Cote, L. J., Andrews, H., Fahn, S., Waters, C., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000276989.17578.02 · Cited by 253

Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments

Ksiȩżak-Reding, H., Liu, W.-K., & Yen, S.-H. C. (1992) · Brain Research · doi:10.1016/0006-8993(92)91476-u · Cited by 249

A Dengue Fever Viremia Model in Mice Shows Reduction in Viral Replication and Suppression of the Inflammatory Response after Treatment with Antiviral Drugs

Schul, W., Liu, W., Xu, H., Flamand, M., & Vasudevan, S. G. (2007) · The Journal of Infectious Diseases · doi:10.1086/511310 · Cited by 248

Cholera toxin structure, gene regulation and pathophysiological and immunological aspects

Sánchez, J., & Holmgren, J. R. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7496-5 · Cited by 239

Chemical Approaches to Glycobiology

Kiessling, L. L., & Splain, R. A. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.070606.100917 · Cited by 238

O Glycosylation of an Sp1-Derived Peptide Blocks Known Sp1 Protein Interactions

Roos, M. D., Su, K., Baker, J. R., & Kudlow, J. E. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6472 · Cited by 223

α-Glucosidase Inhibitors Reduce Dengue Virus Production by Affecting the Initial Steps of Virion Morphogenesis in the Endoplasmic Reticulum

Courageot, M.-P., Frenkiel, M., dos Santos, C. N. D., Deubel, V., & Desprès, P. (2000) · Journal of Virology · doi:10.1128/jvi.74.1.564-572.2000 · Cited by 213

Characterization and dynamics of O-linked glycosylation of human cytokeratin 8 and 18.

Chou, C.-F., Smith, A. J., & Omary, M. B. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50611-1 · Cited by 212

Iminosugars: from botanical curiosities to licensed drugs

WINCHESTER, B. G. (2009) · Tetrahedron Asymmetry · doi:10.1016/j.tetasy.2009.02.048 · Cited by 195

Storage solutions: treating lysosomal disorders of the brain

Jeyakumar, M., Dwek, R. A., Butters, T. D., & Platt, F. M. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1725 · Cited by 192

The alpha-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth.

Пили, Р., Chang, J., Partis, R. A., Mueller, R. A., Chrest, F. J., & Passaniti, A. (1995) · PubMed · Cited by 192

4-Aryl-1,2,3-triazole: A Novel Template for a Reversible Methionine Aminopeptidase 2 Inhibitor, Optimized To Inhibit Angiogenesis in Vivo

Kallander, L. S., Lu, Q., Chen, W., Tomaszek, T. A., Yang, G. X., Tew, D. G., Meek, T. D., Hofmann, G. A., Schulz-Pritchard, C. K., Smith, W. W., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050408c · Cited by 189

A plasmid of Rhizobium meliloti 41 encodes catabolism of two compounds from root exudate of Calystegium sepium

Tepfer, D. A., Goldmann, A., Pamboukdjian, N., Maille, M., Lépingle, A., Chevalier, D., Dénarié, J., & Rosenberg, C. (1988) · Journal of Bacteriology · doi:10.1128/jb.170.3.1153-1161.1988 · Cited by 186

Australine, a Novel Pyrrolizidine Alkaloid Glucosidase Inhibitor from Castanospermum australe

Molyneux, R. J., Benson, M. E., Wong, R. Y., Tropea, J. E., & Elbein, A. D. (1988) · Journal of Natural Products · doi:10.1021/np50060a024 · Cited by 183

Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function

Jank, T., Giesemann, T., & Aktories, K. (2007) · Glycobiology · doi:10.1093/glycob/cwm004 · Cited by 183

Recent Developments in the Synthesis of Pyrrolidine‐Containing Iminosugars

Stocker, B. L., Dangerfield, E. M., Win‐Mason, A. L., Haslett, G. W., & Timmer, M. S. M. (2010) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200901320 · Cited by 181

O -GlcNAc Signaling in the Cardiovascular System

Ngoh, G. A., Facundo, H. T., Zafir, A., & Jones, S. P. (2010) · Circulation Research · doi:10.1161/circresaha.110.224675 · Cited by 175

Lentiginosine, a dihydroxyindolizidine alkaloid that inhibits amyloglucosidase

Pastuszak, I., Molyneux, R. J., James, L. F., & Elbein, A. D. (1990) · Biochemistry · doi:10.1021/bi00459a032 · Cited by 173

Dynamic O-GlcNAcylation of the Small Heat Shock Protein αB-Crystallin

Roquemore, E. P., Chevrier, M. R., Cotter, R. J., & Hart, G. W. (1996) · Biochemistry · doi:10.1021/bi951918j · Cited by 171

Site‐specific interplay between O‐GlcNAcylation and phosphorylation in cellular regulation

Hu, P., Shimoji, S., & Hart, G. W. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.04.044 · Cited by 170

Tactics and strategies for the synthesis of iminosugar C-glycosides: a review

Compain, P., Chagnault, V., & Martin, O. R. (2009) · Tetrahedron Asymmetry · doi:10.1016/j.tetasy.2009.03.031 · Cited by 167

Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression

Potapenko, I. O., Haakensen, V. D., Lüders, T., Helland, Å., Bukholm, I., Sørlie, T., Kristensen, V. N., Lingjærde, O. C., & Børresen-Dale, A.-L. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2009.12.001 · Cited by 158

GlcNAcstatin: a Picomolar, Selective O-GlcNAcase Inhibitor That Modulates Intracellular O-GlcNAcylation Levels

Dorfmueller, H. C., Borodkin, V. S., Schimpl, M., Shepherd, S. M., Shpiro, N., & van Aalten, D. M. F. (2006) · Journal of the American Chemical Society · doi:10.1021/ja066743n · Cited by 157

N‐Acetylgucosaminono‐1,5‐lactone oxime and the corresponding (phenylcarbamoyl)oxime

Horsch, M., Hoesch, L., Vasella, A. T., & Rast, D. M. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb15976.x · Cited by 156

The 3-dimensional structure of a hepatitis C virus p7 ion channel by electron microscopy

Luik, P., Chew, C. F., Aittoniemi, J., Chang, J. P.-E., Wentworth, P., Dwek, R. A., Biggin, P. C., Vénien‐Bryan, C., & Zitzmann, N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905966106 · Cited by 156

The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding

Fischer, P. B., Collin, M., Karlsson, G. B., James, W., Butters, T. D., Davis, S. J., Gordon, S., Dwek, R. A., & Platt, F. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5791-5797.1995 · Cited by 155

Study of the Mechanism of Antiviral Action of Iminosugar Derivatives against Bovine Viral Diarrhea Virus

Durantel, D., Branza‐Nichita, N., Carrouée‐Durantel, S., Butters, T. D., Dwek, R. A., & Zitzmann, N. (2001) · Journal of Virology · doi:10.1128/jvi.75.19.8987-8998.2001 · Cited by 155

The Role of Glucocerebrosidase Mutations in Parkinson Disease and Lewy Body Disorders

Velayati, A., Yu, W. H., & Sidransky, E. (2010) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-010-0102-x · Cited by 151

Sialidase and malignancy: A minireview

Miyagi, T., Wada, T., Yamaguchi, K., & Hata, K. (2003) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000024250.48506.bf · Cited by 148

Rescue of functional delF508‐CFTR channels in cystic fibrosis epithelial cells by the α‐glucosidase inhibitor miglustat

Norez, C., Noël, S., Wilke, M., Bijvelds, M. J. C., Jorna, H., Melin‐Heschel, P., de Jonge, H. R., & Becq, F. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.03.010 · Cited by 143

Protein toxins from plants and bacteria: Probes for intracellular transport and tools in medicine

Sandvig, K., Torgersen, M. L., Engedal, N., Skotland, T., & Iversen, T. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.04.008 · Cited by 140

Therapy for lysosomal storage disorders

Beck, M. (2009) · IUBMB Life · doi:10.1002/iub.284 · Cited by 139

The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic β-cell O-GlcNAc-selective N-acetyl-β-d-glucosaminidase

Konrad, R. J., Mikolaenko, I., Tolar, J. F., Kan, L. I. U., & Kudlow, J. E. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3560031 · Cited by 138

Over-expression of ST3Gal-I promotes mammary tumorigenesis

Picco, G., Julien, S., Brockhausen, I., Beatson, R., Antonopoulos, A., Haslam, S. M., Mandel, U., Dell, A., Pinder, S. E., Taylor‐Papadimitriou, J., et al. (2010) · Glycobiology · doi:10.1093/glycob/cwq085 · Cited by 138

Natural and Synthetic Iminosugars as Carbohydrate Processing Enzyme Inhibitors for Cancer Therapy

Wrodnigg, T., Steiner, A., & Ueberbacher, B. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008783330851 · Cited by 134

Polyhydroxylated pyrrolidine and pyrrolizidine alkaloids from Hyacinthoides non-scripta and Scilla campanulata

Kato, A., Adachi, I., Miyauchi, M., Ikeda, K., Komae, T., Kizu, H., Kameda, Y., Watson, A. A., Nash, R. J., Wormald, M. R., et al. (1999) · Carbohydrate Research · doi:10.1016/s0008-6215(99)00043-9 · Cited by 128

Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathy

Ohmi, K., Kudo, L. C., Ryazantsev, S., Zhao, H., Karsten, S. L., & Neufeld, E. F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903223106 · Cited by 127

Isolation from and x-ray crystal structure of alexine, (1r,2r,3r,7s,8s)-3-hydroxymethyl-1,2,7-trihydroxypyrrolizidine [(2r,3r,4r,5s,6s)-2-hydroxymethyl-1-azabicyclo[3.3.0]octan-3,4,6-triol], a unique pyrrolizidine alkaloid

Nash, R. J., Fellows, L. E., Dring, J. V., Fleet, G. W. J., Derome, A. E., Hamor, T. A., Scofield, A. M., & Watkin, D. J. (1988) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)87914-9 · Cited by 126

Chemical Probes of UDP-Galactopyranose Mutase

Carlson, E. E., May, J. F., & Kiessling, L. L. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.06.007 · Cited by 126

Golgi α-mannosidase II cleaves two sugars sequentially in the same catalytic site

Shah, N., Kuntz, D. A., & Rose, D. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802206105 · Cited by 126

Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel

Griffin, S. D. C., StGelais, C., Owsianka, A. M., Patel, A. H., Rowlands, D. J., & Harris, M. (2008) · Hepatology · doi:10.1002/hep.22555 · Cited by 124

Pharmacological Enhancement of Mutated α-Glucosidase Activity in Fibroblasts from Patients with Pompe Disease

Parenti, G., Zuppaldi, A., Pittis, M. G., Tuzzi, M. R., Annunziata, I., Meroni, G., Porto, C., Donaudy, F., Rossi, B., Rossi, M., et al. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300074 · Cited by 121

The structure of nojirimycin, a piperidinose sugar antibiotic.

Inouye, S., Tsuruoka, T., & Nida, T. (1966) · PubMed · Cited by 120

Carbohydrate building blocks

Kennedy, J. F., & Norris, T. A. (1997) · Carbohydrate Polymers · doi:10.1016/s0144-8617(97)89993-6 · Cited by 120

Dynamic Glycosylation of the Transcription Factor CREB: A Potential Role in Gene Regulation

Lamarre-Vincent, N., & Hsieh‐Wilson, L. C. (2003) · Journal of the American Chemical Society · doi:10.1021/ja028200t · Cited by 119

A method for assaying the rhamnosidase activity of naringinase

Romero, C., Manjón, A., Bastida, J., & Iborra, J. L. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90614-1 · Cited by 117

D ‐Fructose‐6‐phosphate Aldolase in Organic Synthesis: Cascade Chemical‐Enzymatic Preparation of Sugar‐Related Polyhydroxylated Compounds

Concia, A. L., Lozano, C., Castillo, J. A., Parella, T., Joglar, J., & Clapés, P. (2009) · Chemistry - A European Journal · doi:10.1002/chem.200802532 · Cited by 117

Monosaccharide mit stickstoffhaltigem Ring, XIII. Synthese und Reaktionen von Keto‐piperidinosen

Paulsen, H. M., Sangster, I., & Heyns, K. (1967) · Chemische Berichte · doi:10.1002/cber.19671000314 · Cited by 116

Altered Glycosylation of Proteins in Cancer: What Is the Potential for New Anti-Tumour Strategies

Brooks, S. A., Carter, T. M., Royle, L., Harvey, D. J., Fry, S., Kinch, C., Dwek, R. A., & Rudd, P. M. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008783330860 · Cited by 116

Reducing Glycosphingolipid Content in Adipose Tissue of Obese Mice Restores Insulin Sensitivity, Adipogenesis and Reduces Inflammation

van Eijk, M., Aten, J., Bijl, N., Ottenhoff, R., van Roomen, C. P. A. A., Dubbelhuis, P. F., Seemann, I., der Vlugt, K. G., Overkleeft, H. S., ARBEENY, C. M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004723 · Cited by 115

Carbohydrate building blocks

Bols, M. (1995) · Cited by 113

Nagstatin, a new inhibitor of N-acetyl-.BETA.-D-glucosaminidase, produced by Streptomyces amakusaensis MG846-fF3. Taxonomy, production, isolation, physico-chemical properties and biological activities.

AOYAGI, T., Suda, H., Uotani, K., Kojima, F., Aoyama, T., HORIGUCHI, K., HAMADA, M., & TAKEUCHI, T. (1992) · The Journal of Antibiotics · doi:10.7164/antibiotics.45.1404 · Cited by 111

Gaucher disease

Butters, T. D. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.05.035 · Cited by 109

Casuarine: A very highly oxygenated pyrrolizidine alkaloid

Nash, R. J., Thomas, P. I., Waigh, R. D., Fleet, G. W. J., Wormald, M. R., Lilley, P. M. D. Q., & Watkin, D. J. (1994) · Tetrahedron Letters · doi:10.1016/0040-4039(94)80134-7 · Cited by 107

Isolation and structure of an unusual cyclic amino alditol from a legume

Fellows, L. E., Bell, E. A., Lynn, D. G., Pilkiewicz, F. G., Miura, I., & Nakanishi, K. (1979) · Journal of the Chemical Society Chemical Communications · doi:10.1039/c39790000977 · Cited by 104

Synthesis of (+)-Casuarine

Denmark, S. E., & Hurd, A. R. (2000) · The Journal of Organic Chemistry · doi:10.1021/jo991680v · Cited by 104

Clues to Neuro-Degeneration in Niemann-Pick Type C Disease from Global Gene Expression Profiling

Reddy, J. V., Ganley, I. G., & Pfeffer, S. R. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000019 · Cited by 104

Large clostridial cytotoxins: cellular biology of Rho/Ras-glucosylating toxins

SCHIRMER, J. (2004) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.03.014 · Cited by 104

Inhibition of HIV and SIV infectivity by blockade of α-glucosidase activity

Ratner, L., Heyden, N. V., & Dedera, D. A. (1991) · Virology · doi:10.1016/0042-6822(91)90483-r · Cited by 103

Miglitol, a new α-glucosidase inhibitor

Sels, J.-P. J. E., Huijberts, M. S., & Wolffenbuttel, B. H. R. (1999) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.1.149 · Cited by 103

Studies of an immunomodulator, swainsonine. II. Effect of swainsonine on mouse immunodeficient system and experimental murine tumor.

KINO, T., Inamura, N., Nakahara, K., KIYOTO, S., Goto, T., Terano, H., KOHSAKA, M., AOKI, H., & Imanaka, H. (1985) · The Journal of Antibiotics · doi:10.7164/antibiotics.38.936 · Cited by 103

Niemann–Pick type C disease: Accelerated neurofibrillary tangle formation and amyloid β deposition associated with apolipoprotein E ε4 homozygosity

Saito, Y., Suzuki, K., Nanba, E., Yamamoto, T., Ohno, K., & Murayama, S. (2002) · Annals of Neurology · doi:10.1002/ana.10266 · Cited by 101

Dual-Action Lipophilic Iminosugar Improves Glycemic Control in Obese Rodents by Reduction of Visceral Glycosphingolipids and Buffering of Carbohydrate Assimilation

Wennekes, T., Meijer, A. J., Groen, A. K., Boot, R. G., Groener, J. E. M., van Eijk, M., Ottenhoff, R., Bijl, N., der Vlugt, K. G., Song, H., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901281m · Cited by 98

Inhibitors of the Purine Salvage Pathway: A Valuable Approach for Antiprotozoal Chemotherapy?

Berg, M., der Veken, P. V., Goeminne, A., Haemers, A., & Augustyns, K. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791556023 · Cited by 98

Celgosivir, an alpha-glucosidase I inhibitor for the potential treatment of HCV infection.

Durantel, D. (2009) · PubMed · Cited by 96

Functionalized Pyrrolidines Inhibit α-Mannosidase Activity and Growth of Human Glioblastoma and Melanoma Cells

Fiaux, H., Popowycz, F., Favre, S., Schütz, C. A., Vogel, P., Gerber‐Lemaire, S., & Juillerat‐Jeanneret, L. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0409019 · Cited by 95

GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation

Dorfmueller, H. C., Borodkin, V. S., Schimpl, M., & van Aalten, D. M. F. (2009) · Biochemical Journal · doi:10.1042/bj20090110 · Cited by 94

Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among Taiwanese

Wu, Y., Chen, C., Chao, C.-Y., Ro, L.-S., Lyu, R.-K., Chang, K., & Lee-Chen, G.-J. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.105940 · Cited by 90

Quantitative determination of 1-deoxynojirimycin in mulberry leaves using liquid chromatography–tandem mass spectrometry

Nuengchamnong, N., Ingkaninan, K., Kaewruang, W., Wongareonwanakij, S., & Hongthongdaeng, B. (2007) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2007.03.031 · Cited by 88

Glycomimetics at the Mirror: Medicinal Chemistry of L-Iminosugars

D’Alonzo, D., Guaragna, A., & Palumbo, G. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787315540 · Cited by 88

Action of Celgosivir (6O-Butanoyl Castanospermine) against the Pestivirus BVDV: Implications for the Treatment of Hepatitis C

Whitby, K., Taylor, D. L., Patel, D., Ahmed, P. S., & Tyms, A. S. (2004) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020401500304 · Cited by 87

The structure of nagstatin, a new inhibitor of N-acetyl-.BETA.-D-glucosaminidase.

Aoyama, T., NAGANAWA, H., Suda, H., UOTAN, K., AOYAGI, T., & TAKEUCHI, T. (1992) · The Journal of Antibiotics · doi:10.7164/antibiotics.45.1557 · Cited by 86

Novel Imino Sugar Derivatives Demonstrate Potent Antiviral Activity against Flaviviruses

Chang, J., Wang, L., Ma, D., Qu, X., Guo, H., Xu, X., Mason, P. M., Bourne, N., Moriarty, R. M., Gu, B., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01457-08 · Cited by 86

Targeting the forgotten transglycosylases

Halliday, J. A., McKeveney, D., Muldoon, C. A., Premraj, R., & Meutermans, W. D. F. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.030 · Cited by 85

ZITZMANN, NICOLE (Nicole)

Zitzmann, N. (1999) · Cited by 81

Novel glycosidase inhibitors, nojirimycin B and D-mannonic-.DELTA.-lactam. Isolation, structure determination and biological property.

NIWA, T., Tsuruoka, T., Goi, H., Kodama, Y., Itoh, J., Inouye, S., Yamada, Y., NIIDA, T., NOBE, M., & Ogawa, Y. (1984) · The Journal of Antibiotics · doi:10.7164/antibiotics.37.1579 · Cited by 80

Glycosylation Pathways as Drug Targets for Cancer: Glycosidase Inhibitors

Gerber‐Lemaire, S., & Juillerat-Jeanneret, L. (2006) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955706778195162 · Cited by 79

Elevation of Global O-GlcNAc in Rodents Using a Selective O-GlcNAcase Inhibitor Does Not Cause Insulin Resistance or Perturb Glucohomeostasis

Macauley, M. S., Shan, X., Yuzwa, S. A., Gloster, T. M., & Vocadlo, D. J. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.07.005 · Cited by 78

Analysis of the Human Cancer Glycome Identifies a Novel Group of Tumor-Associated N -Acetylglucosamine Glycan Antigens

Satomaa, T., Heiskanen, A., Leonardsson, I., Ångström, J., Olonen, A., Blomqvist, M., Salovuori, N., Haglund, C. H., Teneberg, S., Natunen, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-0289 · Cited by 78

Inhibition of O-GlcNAcase Using a Potent and Cell-Permeable Inhibitor Does Not Induce Insulin Resistance in 3T3-L1 Adipocytes

Macauley, M. S., He, Y., Gloster, T. M., Stubbs, K. A., Davies, G. J., & Vocadlo, D. J. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.07.006 · Cited by 78

Tau deletion exacerbates the phenotype of Niemann–Pick type C mice and implicates autophagy in pathogenesis

Pacheco, C. D., Elrick, M. J., & Lieberman, A. P. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn423 · Cited by 77

New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat

Wraith, E. (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s5777 · Cited by 76

General Methods for Iminosugar Synthesis

Cipolla, L., Ferla, B. L., & Nicotra, F. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452429 · Cited by 75

Third-Generation Immucillins: Syntheses and Bioactivities of Acyclic Immucillin Inhibitors of Human Purine Nucleoside Phosphorylase

Clinch, K., Evans, G. B., Fröhlich, R. F. G., Furneaux, R. H., Kelly, P. M., Legentil, L., Murkin, A. S., Li, L., Schramm, V. L., Tyler, P. C., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801421q · Cited by 72

Maintaining Low Ca2+ Level in the Endoplasmic Reticulum Restores Abnormal Endogenous F508del‐CFTR Trafficking in Airway Epithelial Cells

Norez, C., Antigny, F., Becq, F., & Vandebrouck, C. (2006) · Traffic · doi:10.1111/j.1600-0854.2006.00409.x · Cited by 71

Glycoproteomic Analyses of Ovarian Cancer Cell Lines and Sera from Ovarian Cancer Patients Show Distinct Glycosylation Changes in Individual Proteins

Li, B., An, H. J., Kirmiz, C., Lebrilla, C. B., Lam, K. S., & Miyamoto, S. (2008) · Journal of Proteome Research · doi:10.1021/pr800297u · Cited by 70

Molecular Basis for Inhibition of GH84 Glycoside Hydrolases by Substituted Azepanes: Conformational Flexibility Enables Probing of Substrate Distortion

Marcelo, F., He, Y., Yuzwa, S. A., Nieto, L., Jiménez‐Barbero, J., Sollogoub, M., Vocadlo, D. J., Davies, G. J., & Blériot, Y. (2009) · Journal of the American Chemical Society · doi:10.1021/ja809776r · Cited by 70

Synthesis and mannosidase inhibitory activity of 3-benzyloxymethyl analogs of swainsonine

Pearson, W. H., & Guo, L. (2001) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)01777-4 · Cited by 70

Chemical modification of the glucosidase inhibitor 1-deoxynojirimycin. Structure-activity relationships

Tan, A. K., van den Broek, L. A. M., van Boeckel, S., Ploegh, H. L., & Bolscher, J. G. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98715-6 · Cited by 67

N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery

Pollock, S., Dwek, R. A., Burton, D. R., & Zitzmann, N. (2008) · AIDS · doi:10.1097/qad.0b013e32830efd96 · Cited by 67

Design, Synthesis, and Biological Evaluation of Enantiomeric β‐N‐Acetylhexosaminidase Inhibitors LABNAc and DABNAc as Potential Agents against Tay‐Sachs and Sandhoff Disease

Rountree, J. S. S., Butters, T. D., Wormald, M. R., Boomkamp, S. D., Dwek, R. A., Asano, N., Ikeda, K., Evinson, E. L., Nash, R. J., & Fleet, G. W. J. (2009) · ChemMedChem · doi:10.1002/cmdc.200800350 · Cited by 67

Azasugar-Based MMP/ADAM Inhibitors as Antipsoriatic Agents

Moriyama, H., Tsukida, T., Inoue, Y., Yokota, K., Yoshino, K., Kondo, H., Miura, N., & Nishimura, S. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0304313 · Cited by 66

Inhibition of O-GlcNAcase Using a Potent and Cell-Permeable Inhibitor Does Not Induce Insulin Resistance in 3T3-L1 Adipocytes

Macauley, M. S., He, Y., Gloster, T. M., Stubbs, K. A., Davies, G. J., & Vocadlo, D. J. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.10.006 · Cited by 66

Suppressive effects of swainsonine on C6 glioma cell in vitro and in vivo

Sun, J., Yang, H., Miao, S., Li, J., Wang, S., Zhu, M., Xie, Y., Wang, J., Liu, Z., & Yang, Q. (2009) · Phytomedicine · doi:10.1016/j.phymed.2009.02.012 · Cited by 64

Synthetic Iminosugar Derivatives as New Potential Immunosuppressive Agents

Ye, X., Sun, F., Liu, M., Li, Q., Wang, Y., Zhang, G., Zhang, L., & Zhang, X. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050169t · Cited by 64

Inhibition of Mouse Tumor Metastasis with Nojirimycin-related Compounds.

Tsuruoka, T., FUKUYASU, H., ISHII, M., USUI, T., Shibahara, S., & Inouye, S. (1996) · The Journal of Antibiotics · doi:10.7164/antibiotics.49.155 · Cited by 63

Determination of iminosugars in mulberry leaves and silkworms using hydrophilic interaction chromatography–tandem mass spectrometry

Nakagawa, K., Ogawa, K., Higuchi, O., Kimura, T., Miyazawa, T., & Hori, M. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.05.007 · Cited by 63

Iodine-mediated ring-closing iodoamination with concomitant N-debenzylation for the asymmetric synthesis of polyhydroxylated pyrrolidines

Davies, S. G., Nicholson, R. L., Price, P. D., Roberts, P. M., Russell, A. J., Savory, E. D., Smith, A. D., & Thomson, J. E. (2009) · Tetrahedron Asymmetry · doi:10.1016/j.tetasy.2009.02.014 · Cited by 63

Inhibition of O-GlcNAcase by a gluco-configured nagstatin and a PUGNAc–imidazole hybrid inhibitor

Shanmugasundaram, B., Debowski, A. W., Dennis, R. J., Davies, G. J., Vocadlo, D. J., & Vasella, A. T. (2006) · Chemical Communications · doi:10.1039/b612154c · Cited by 63

Convergent and Stereoselective Synthesis of Iminosugar-Containing Galfand UDP-GalfMimicks: Evaluation as Inhibitors of UDP-Gal Mutase

Liautard, V., Desvergnes, V., Itoh, K., Liu, H., & Martin, O. R. (2008) · The Journal of Organic Chemistry · doi:10.1021/jo8001134 · Cited by 62

Accumulation of Intracellular Amyloid-β Peptide (Aβ 1–40) in Mucopolysaccharidosis Brains

Ginsberg, S. D., Galvin, J. E., Lee, V. M. ‐., RORKE, L. B., Dickson, D. W., Wolfe, J. H. N., JONES, M. Z., & Trojanowski, J. Q. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199908000-00004 · Cited by 61

Antiviral Profiles of Novel Iminocyclitol Compounds against Bovine Viral Diarrhea Virus, West Nile Virus, Dengue Virus and Hepatitis B Virus

Gu, B., Mason, P. W., Wang, L., Norton, P. A., Bourne, N., Moriarty, R. M., Mehta, A. S., Despande, M., Shah, R., & Block, T. M. (2007) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020701800105 · Cited by 60

Synthesis of the New Mannosidase Inhibitors, Diversity-Oriented 5-Substituted Swainsonine Analogues, via Stereoselective Mannich Reaction

Fujita, T., Nagasawa, H., Uto, Y., Hashimoto, T., Asakawa, Y., & Hori, H. (2004) · Organic Letters · doi:10.1021/ol049947m · Cited by 59

Bacterial transglycosylase inhibitors

Ostash, B., & Walker, S. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.08.014 · Cited by 58

Synthesis of Naturally Occurring Nitrogen Heterocycles from Carbohydrates

(2005) · Wiley eBooks · doi:10.1002/9780470988619 · Cited by 58

Natural iminosugar derivatives of 1-deoxynojirimycin inhibit glycosylation of hepatitis viral envelope proteins.

Jacob, J. R., Mansfield, K. G., You, J. E., Tennant, B. C., & Kim, Y. H. (2007) · PubMed · Cited by 57

Bacterial toxin and effector glycosyltransferases

Belyi, Y., & Aktories, K. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.07.022 · Cited by 57

Anti-inflammatory effect of miglustat in bronchial epithelial cells

Dechecchi, M. C., Nicolis, E., Norez, C., Bezzerri, V., Borgatti, M., Mancini, I., Rizzotti, P., Ribeiro, C. M. P., Gambari, R., Becq, F., et al. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.06.002 · Cited by 57

Looking glass inhibitors: l -DMDP, a more potent and specific inhibitor of α-glucosidases than the enantiomeric natural product DMDP

Yu, C., Asano, N., Ikeda, K., Wang, M., Butters, T. D., Wormald, M. R., Dwek, R. A., Winters, A. L., Nash, R. J., & Fleet, G. W. J. (2004) · Chemical Communications · doi:10.1039/b406035k · Cited by 57

Looking glass inhibitors: scalable syntheses of DNJ, DMDP, and (3R)-3-hydroxy-l-bulgecinine from d-glucuronolactone and of l-DNJ, l-DMDP, and (3S)-3-hydroxy-d-bulgecinine from l-glucuronolactone. DMDP inhibits β-glucosidases and β-galactosidases whereas l-DMDP is a potent and specific inhibitor of α-glucosidases

Best, D., Wang, C., Weymouth‐Wilson, A. C., Clarkson, R. A., Wilson, F. X., Nash, R. J., Miyauchi, S., Kato, A., & Fleet, G. W. J. (2010) · Tetrahedron Asymmetry · doi:10.1016/j.tetasy.2010.01.017 · Cited by 55

Glucosidase inhibitors as antiviral agents for hepatitis B and C.

Durantel, D., Alotte, C., & Zoulim, F. (2007) · PubMed · Cited by 53

Structural Investigation of the Binding of 5‐Substituted Swainsonine Analogues to Golgi α‐Mannosidase II

Kuntz, D. A., Nakayama, S., Shea, K., Hori, H., Uto, Y., Nagasawa, H., & Rose, D. R. (2010) · ChemBioChem · doi:10.1002/cbic.200900750 · Cited by 51

Parallel Improvement of Sodium and Chloride Transport Defects by Miglustat (n-Butyldeoxynojyrimicin) in Cystic Fibrosis Epithelial Cells

Noël, S., Wilke, M., Bot, A. G. M., de Jonge, H. R., & Becq, F. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.135582 · Cited by 50

Swainsonine, a glycosylation inhibitor, enhances both lymphocyte efficacy and tumour susceptibility in LAK and NK cytotoxicity

Galustian, C., Foulds, S., Dye, J. F., & Guillou, P. J. (1994) · Immunopharmacology · doi:10.1016/0162-3109(94)90051-5 · Cited by 50

Airway Delivery of Low-Dose Miglustat Normalizes Nasal Potential Difference in F508del Cystic Fibrosis Mice

Lubamba, B., Lebacq, J., Lebecque, P., Rita Vanbever, A., Leonard, A., Wallemacq, P. E., & Leal, T. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200901-0049oc · Cited by 50

Synthesis of the naringinase inhibitors l-swainsonine and related 6-C-methyl-l-swainsonine analogues: (6R)-C-methyl-l-swainsonine is a more potent inhibitor of l-rhamnosidase by an order of magnitude than l-swainsonine

Håkansson, A. E., van Ameijde, J., Horne, G., Nash, R. J., Wormald, M. R., Kato, A., Besra, G. S., Gurcha, S. S., & Fleet, G. W. J. (2007) · Tetrahedron Letters · doi:10.1016/j.tetlet.2007.10.142 · Cited by 49

Cystic fibrosis and diabetes: isoLAB and isoDAB, enantiomeric carbon-branched pyrrolidine iminosugars

Best, D., Jenkinson, S. F., Saville, A. W., Alonzi, D. S., Wormald, M. R., Butters, T. D., Norez, C., Becq, F., Blériot, Y., Adachi, I., et al. (2010) · Tetrahedron Letters · doi:10.1016/j.tetlet.2010.05.131 · Cited by 48

Inhibition by nojirimycin and 1-deoxynojirimycin of microsomal glucosidases from calf liver acting on the glycoprotein oligosaccharides Glc1–3Man9GlcNAc2

Hettkamp, H., Bause, E., & Legler, G. (1982) · Bioscience Reports · doi:10.1007/bf01114896 · Cited by 48

The novel proapoptotic activity of nonnatural enantiomer of Lentiginosine

Macchi, B., Minutolo, A., Grelli, S., Cardona, F., Cordero, F. M., Mastino, A., & Brandi, A. (2010) · Glycobiology · doi:10.1093/glycob/cwp202 · Cited by 47

A Glycomics Approach to the Discovery of Potential Cancer Biomarkers

An, H. J., & Lebrilla, C. B. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-454-8_14 · Cited by 45

1-Deoxynojirimycin Inhibits Metastasis of B16F10 Melanoma Cells by Attenuating the Activity and Expression of Matrix Metalloproteinases-2 and -9 and Altering Cell Surface Glycosylation

Wang, R.-J., Yang, C., & Hu, M. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf101401b · Cited by 45

Hybrid angiogenesis inhibitors: Synthesis and biological evaluation of bifunctional compounds based on 1-deoxynojirimycin and aryl-1,2,3-triazoles

Zhou, Y., Zhao, Y., Boyle, K. M. O., & Murphy, P. V. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.12.034 · Cited by 44

A Concise Synthesis of Castanospermine by the Use of a Transannular Cyclization

Jensen, T., Mikkelsen, M. S., Lauritsen, A., Andresen, T. L., Gotfredsen, C. H., & Madsen, R. (2009) · The Journal of Organic Chemistry · doi:10.1021/jo9019495 · Cited by 44

The substrate-specificity of human lysosomal α- d -mannosidase in relation to genetic α-mannosidosis

Daher, S. A., Gasperi, R. D., Daniel, P., Hall, N. A., Warren, C. D., & WINCHESTER, B. G. (1991) · Biochemical Journal · doi:10.1042/bj2770743 · Cited by 44

Imino Sugars That are Less Toxic but More Potent as Antivirals, In Vitro, Compared with N-n-Nonyl DNJ

Mehta, A. S., Ouzounov, S., Jordan, R., Simsek, E., Lu, X., Moriarty, R. M., Jacob, G., Dwek, R. A., & Block, T. M. (2002) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020201300505 · Cited by 44

Structural analyses of enzymes involved in the O-GlcNAc modification

Martinez-Fleites, C., He, Y., & Davies, G. J. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.07.019 · Cited by 43

A Rapid Synthesis of Hexofuranose-like Iminosugars Using Ring-Closing Metathesis

Cren, S., Wilson, C., & Thomas, N. R. (2005) · Organic Letters · doi:10.1021/ol051232b · Cited by 43

Combinatorial approach toward synthesis of small molecule libraries as bacterial transglycosylase inhibitors

Shih, H., Chen, K., Chen, S.-K., Huang, C., Cheng, T.-J. R., Ma, C., Wong, C., & Cheng, W. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/c000622j · Cited by 42

Synthesis of 1-Deoxy-1-hydroxymethyl- and 1-Deoxy-1-epi-hydroxymethyl Castanospermine as New Potential Immunomodulating Agents

Vyavahare, V. P., Chakraborty, C., Maity, B., Chattopadhyay, S., Puranik, V. G., & Dhavale, D. D. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070660f · Cited by 41

Glycosylation processing inhibition by castanospermine prevents experimental autoimmune encephalomyelitis by interference with IL-2 receptor signal transduction

Walter, S., Fassbender, K., Gulbins, E., Liu, Y., Rieschel, M., Herten, M., Bertsch, T., & Engelhardt, B. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00308-9 · Cited by 41

Forodesine (BCX-1777, Immucillin H) - A New Purine Nucleoside Analogue: Mechanism of Action and Potential Clinical Application

Korycka, A., Błoński, J. Z., & Robak, T. (2007) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955707781662636 · Cited by 41

Species Dependent Esterase Activities for Hydrolysis of an Anti-HIV Prodrug Glycovir and Bioavailability of Active SC-48334

Cook, C. S., Karabatsos, P. J., Schoenhard, G. L., & Karim, A. (1995) · Pharmaceutical Research · doi:10.1023/a:1016259826037 · Cited by 40

Synthesis of N‐Acetylglucosamine‐Derived Nagstatin Analogues and Their Evaluation as Glycosidase Inhibitors

Terinek, M., & Vasella, A. T. (2005) · Helvetica Chimica Acta · doi:10.1002/hlca.200490286 · Cited by 40

The Structure of a New Piperidine Derivative from Buckwheat Seeds (Fagopyrum esculentum Moench)

ISOBE, M., & Sakamura, S. (1974) · Agricultural and Biological Chemistry · doi:10.1271/bbb1961.38.1111 · Cited by 40

Iminosugars from Baphia nitida Lodd.

Kato, A., Kato, N., Miyauchi, S., Minoshima, Y., Adachi, I., Ikeda, K., Asano, N., Watson, A. A., & Nash, R. J. (2008) · Phytochemistry · doi:10.1016/j.phytochem.2007.11.018 · Cited by 38

Inhibitors of glycoprotein processing alter T-cell proliferative responses to antigen and to interleukin 2.

Wall, K. A., Pierce, J. D., & Elbein, A. D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5644 · Cited by 37

Synthesis of l -altro-1-Deoxynojirimycin, d -allo-1-Deoxynojirimycin, and d -galacto-1-Deoxynojirimycin from a Single Chiral Cyanohydrin

van den Nieuwendijk, A. M. C. H., Ruben, M., Engelsma, S. E., Risseeuw, M., van den Berg, R. J. B. H. N., Boot, R. G., Aerts, J. M. F. G., Brussee, J., van der MAREL, G. A., & Overkleeft, H. S. (2010) · Organic Letters · doi:10.1021/ol101556k · Cited by 37

Molecular interaction of imino sugars with human α-galactosidase: Insight into the mechanism of complex formation and pharmacological chaperone action in Fabry disease

Sugawara, K., Tajima, Y., Kawashima, I., Tsukimura, T., Saito, S., Ohno, K., Iwamoto, K., Kobayashi, T., Itoh, K., & Sakuraba, H. (2009) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2008.12.017 · Cited by 36

Galactostatin, a new .BETA.-galactosidase inhibitor from Streptomyces lydicus.

Miyake, Y., & Ebata, M. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.122 · Cited by 35

Miglustat: Substrate reduction therapy for glycosphingolipid lysosomal storage disorders

Lachmann, R. (2006) · Drugs of today · doi:10.1358/dot.2006.42.1.937457 · Cited by 34

O-GlcNAc Modification and the Tauopathies: Insights from Chemical Biology

Yuzwa, S. A., & Vocadlo, D. J. (2009) · Current Alzheimer Research · doi:10.2174/156720509789207967 · Cited by 32

Iminosugars as Therapeutic Agents: Recent Advances and Promising Trends

Nash, R. J., Kato, A., Yu, C.-Y., & Fleet, G. W. J. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.117 · Cited by 302

Carbohydrate based Potential Chemotherapeutic Agents: Recent Developments and their Scope in Future Drug Discovery

Tiwari, V. K., Mishra, R. C., Sharma, A., & Tripathi, R. P. (2012) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955712803832654 · Cited by 97

The Multivalent Effect in Glycosidase Inhibition: Probing the Influence of Valency, Peripheral Ligand Structure, and Topology with Cyclodextrin‐Based Iminosugar Click Clusters

Decroocq, C., Joosten, A. Y. P., Sergent, R., Barragán, T. M., Mellet, C. O., & Compain, P. (2013) · ChemBioChem · doi:10.1002/cbic.201300283 · Cited by 61

Looking-Glass Synergistic Pharmacological Chaperones: DGJ and L-DGJ from the Enantiomers of Tagatose

Jenkinson, S. F., Fleet, G. W. J., Nash, R. J., Koike, Y., Adachi, I., Yoshihara, A., Morimoto, K., Izumori, K., & Kato, A. (2011) · Organic Letters · doi:10.1021/ol201552q · Cited by 56

Access to l - and d -Iminosugar C-Glycosides from a d -gluco-Derived 6-Azidolactol Exploiting a Ring Isomerization/Alkylation Strategy

Mondon, M., Fontelle, N., Désiré, J., Lecornué, F., Guillard, J., Marrot, J., & Blériot, Y. (2012) · Organic Letters · doi:10.1021/ol203385w · Cited by 47

Iminosugars: Therapeutic Applications and Synthetic Considerations

Horne, G. (2014) · Topics in medicinal chemistry · doi:10.1007/7355_2014_50 · Cited by 20

Iminosugars

Ramesh, N. G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816675-8.00008-7 · Cited by 11

Recent synthetic strategies to access diverse iminosugars

Matassini, C., & Cardona, F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91729-2.00003-3 · Cited by 2

The synthesis and biology of iminosugars and their precursors

Ayers, B. J., & Ayers, B. (2014) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-eqedyk11r

Iminosugars past, present and future: Medicines for tomorrow

Horne, G., Wilson, F. X., Tinsley, J., Williams, D. H., & Storer, R. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2010.08.017 · Cited by 320